Panclicins A~E are novel and potent pancreatic lipase inhibitors produced by Streptomyces sp. NR 0619. Their structures have been elucidated based on NMR and FAB-MS experiments. The relative configurations have also been determined by NMR experiments. The absolute stereochemistry has been determined by the chiral HPLC analysis of the hydrolysates of panclicins A and B and by modified Mosher's method on a derivative of panclicin A. They are structurally related to β-lactone esterase inhibitors of microbial origin, lipstatin, valilactone, ebelactones and esterastin. Panclicins also contain a β-lactone structure with two alkyl chains, one of which has an N-formylalanyloxy or N-formylglycyloxy substituent. © 1994, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.
CITATION STYLE
Yoshinari, K., Aoki, M., Ohtsuka, T., Nakayama, N., Itezono, Y., Mutoh, M., … Yokose, K. (1994). Panclicins, novel pancreatic lipase inhibitors. II. Structural elucidation. The Journal of Antibiotics, 47(12), 1376–1384. https://doi.org/10.7164/antibiotics.47.1376
Mendeley helps you to discover research relevant for your work.